Abstract: A substrate treating apparatus includes a housing, treating space and support unit to support a substrate, dielectric plate, gas supply unit, and plasma source to generate a plasma and including a top edge electrode above the edge region supported by the support unit and bottom edge electrode below the edge region supported by the support unit, which includes a support plate having an inner space and vacuum hole that communicates with the inner space and sucking the substrate on the top surface. A lift pin assembly can transfer the substrate between an outside transfer unit and the support plate. A decompression unit can apply negative pressure to the inner space. The lift pin assembly includes a base plate and through hole penetrating the base plate to provide negative pressure in a region under the base plate to a region over the base plate. Lift pins protrude from the base plate and support a bottom substrate surface. A driver can lift/lower the base plate within the inner space.

Abstract: A mobility system includes a mobility module that measures and controls a mobility state of the mobility system and an operation module that receives a movement input of the mobility system. The operation module is configured to identify the mobility state through the mobility module, measure a force or torque depending on the movement input, calculate a restoring torque satisfying a critical velocity or a critical acceleration, based on the mobility state and the measured force or torque, and provide feedback on the movement input depending on the determined restoring torque.

Abstract: Disclosed is a novel adsorbent for use in a 99Mo/99mTc generator, which is a medical diagnostic radioisotope generator, and in a 188W/188Re generator, which is a therapeutic radioisotope generator. The adsorbent composed of sulfated alumina or alumina-sulfated zirconia exhibits adsorption capacity superior to that of conventional adsorbents, and is stable and is thus loaded in a dry state in an adsorption column so that the radioisotope 99Mo or 188W can be adsorbed. Thus, it is possible to miniaturize the column, and such a miniaturized column is small, convenient to use, and highly efficient, and extracts a radioisotope satisfying the requirements for pharmaceuticals, and thus can be useful for radioisotope generators extracting 99mTc or 188Re.

Abstract: Disclosed herein is an radioisotope adsorbent including a bifunctional organosilane compound, including an organosiloxane functional group and a phosphate group, bonded on the surface of silica which is a bone structure of the adsorbent, and a method of preparing the radioisotope adsorbent, and a strontium/yttrium generator using the radioisotope adsorbent. Since the radioisotope adsorbent has a high adsorption capacity for 90Y such as 95% extraction efficiency or more from ICi 90Sr/90Y by using a column packed with 0.4 g of the adsorbent with a high-purity of 90Y, it can be usefully to be employed in the fields requiring 90Y.

Abstract: Disclosed is a novel adsorbent for use in a 99Mo/99mTc generator, which is a medical diagnostic radioisotope generator, and in a 188W/188Re generator, which is a therapeutic radioisotope generator. The adsorbent composed of sulfated alumina or alumina-sulfated zirconia exhibits adsorption capacity superior to that of conventional adsorbents, and is stable and is thus loaded in a dry state in an adsorption column so that the radioisotope 99Mo or 188W can be adsorbed. Thus, it is possible to miniaturize the column, and such a miniaturized column is small, convenient to use, and highly efficient, and extracts a radioisotope satisfying the requirements for pharmaceuticals, and thus can be useful for radioisotope generators extracting 99mTc or 188Re.

Abstract: Disclosed herein is an radioisotope adsorbent including a bifunctional organosilane compound, including an organosiloxane functional group and a phosphate group, bonded on the surface of silica which is a bone structure of the adsorbent, and a method of preparing the radioisotope adsorbent, and a strontium/yttrium generator using the radioisotope adsorbent. Since the radioisotope adsorbent has a high adsorption capacity for 90Y such as 95% extraction efficiency or more from ICi 90Sr/90Y by using a column packed with 0.4 g of the adsorbent with a high-purity of 90Y, it can be usefully to be employed in the fields requiring 90Y.

Abstract: Disclosed is a novel adsorbent for use in a 99Mo/99mTc generator, which is a medical diagnostic radioisotope generator, and in a 188W/188Re generator, which is a therapeutic radioisotope generator. The adsorbent composed of sulfated alumina or alumina-sulfated zirconia exhibits adsorption capacity superior to that of conventional adsorbents, and is stable and is thus loaded in a dry state in an adsorption column so that the radioisotope 99Mo or 188W can be adsorbed. Thus, it is possible to miniaturize the column, and such a miniaturized column is small, convenient to use, and highly efficient, and extracts a radioisotope satisfying the requirements for pharmaceuticals, and thus can be useful for radioisotope generators extracting 99mTc or 188Re.

Abstract: Disclosed is a novel adsorbent for use in a 99Mo/99mTc generator, which is a medical diagnostic radioisotope generator, and in a 188W/188Re generator, which is a therapeutic radioisotope generator. The adsorbent composed of sulfated alumina or alumina-sulfated zirconia exhibits adsorption capacity superior to that of conventional adsorbents, and is stable and is thus loaded in a dry state in an adsorption column so that the radioisotope 99Mo or 188W can be adsorbed. Thus, it is possible to miniaturize the column, and such a miniaturized column is small, convenient to use, and highly efficient, and extracts a radioisotope satisfying the requirements for pharmaceuticals, and thus can be useful for radioisotope generators extracting 99mTc or 188Re.

Abstract: Disclosed is an ophthalmic applicator for the treatment of pterygium or or glaucoma using a radioisotope. It comprises a source volume for containing the radioisotope therein; a filter volume for controlling a radiation dose emitted from the radioisotope; and an encapsulation volume for encompassing the source volume and the filter volume, wherein the radioisotope is pure 32P or a combination of 32P and 103Pd. Ensuring the formation of more ideal dose distributions than do the conventional 90Sr ophthalmic applicators, as described hitherto, the ophthalmic applicator for the treatment of pterygium or glaucoma using 32P or a combination of 32P and 103Pd can promise both high therapeutic effects on pterygium or glaucoma and high safety effects on the eye lens. Further, 32P and 103Pd are easier to produce and treat than is 90Sr, thereby allowing the radiotherapy to be useful.

Abstract: A method for distillation of sulfur for preparing radioactive phosphorous nuclide includes the steps of: charging powdered sulfur into a target tube designed to have an upper and a bottom neck; degassing the target tube to form a vacuum therein, followed by heating the upper neck to seal the target tube; irradiating neutrons into the sealed target tube to produce radioactive phosphorous nuclide; heating the distillation zone to distill the remaining unreacted sulfur; and cleaving the target tube at the bottom neck to separate the distillation and the cooling zone from each other, the separated zones containing the radioactive phosphorous nuclide and the unreacted sulfur, respectively, whereby the radioactive phosphorous nuclide of high purity can be prepared while the sulfur can be recovered at high efficiency.

Abstract: A method for distillation of sulfur for preparing radioactive phosphorous nuclide includes the steps of: charging powdered sulfur into a target tube designed to have an upper and a bottom neck; degassing the target tube to form a vacuum therein, followed by heating the upper neck to seal the target tube; irradiating neutrons into the sealed target tube to produce radioactive phosphorous nuclide; heating the distillation zone to distill the remaining unreacted sulfur; and cleaving the target tube at the bottom neck to separate the distillation and the cooling zone from each other, the separated zones containing the radioactive phosphorous nuclide and the unreacted sulfur, respectively, whereby the radioactive phosphorous nuclide of high purity can be prepared while the sulfur can be recovered at high efficiency.